Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma

NCT06676319 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

1147

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Lunsekimig
DRUG: Short-Acting Beta Agonists (SABA)
DRUG: Placebo
DRUG: Fluticasone/Salmeterol
DRUG: Budesonide/Formoterol
DRUG: Budesonide/Albuterol

Sponsor

Sanofi